A Glimpse at the Action of Imatinib Tablets IP 400 mg in Cancer Treatment
Imatinib Tablets IP 400 mg serve an important function in chronic myeloid leukemia (CML) and GIST treatment. This targeted therapy stops the abnormal protein that causes the multiplication of cancer cells, making it excellent in halting disease progression. Doctors normally identify Imatinib Tablets IP 400 mg as a first-line treat for CML, especially in those with Philadelphia chromosome-positive mutation. For patients with GIST, this drug undergoes the tumor growth through the inhibition of tyrosine kinase enzymes. Because of its success rate, Imatinib Tablets IP 400 mg really changed the outcome if a patient was diagnosed early. Consult a healthcare professional before starting any form of treatment.